Drug |
Linearityµg mL-1 |
Intercept |
Slope |
R2 |
SEa |
SEEb |
LODng mL-1 |
LOQng mL-1 |
Isobestic point |
ROS |
0.02-0.64 |
37209 |
385689 |
0.9980 |
0.0083 |
0.0117 |
4 |
12 |
ALP |
0.125-4.0 |
28678 |
82038 |
0.9986 |
0.0608 |
0.0942 |
17 |
52 |
DCL |
0.05-1.60 |
18236 |
229464 |
0.9982 |
0.0169 |
0.0277 |
7 |
22 |
Time program |
ROS |
0.02-0.64 |
33408 |
428502 |
0.9992 |
0.0050 |
0.0074 |
3 |
9 |
ALP |
0.05-1.60 |
45080 |
168733 |
0.9986 |
0.0471 |
0.0668 |
6 |
19 |
DCL |
0.02-0.64 |
27893 |
553467 |
0.9984 |
0.0115 |
0.0180 |
1 |
3 |
Serum |
ROS |
- |
34415 |
393904 |
0.9999 |
0.0053 |
0.0054 |
3 |
9 |
ALP |
- |
24418 |
83294 |
0.9999 |
0.0282 |
0.0311 |
13 |
40 |
DCL |
- |
17455 |
227581 |
0.9999 |
0.0110 |
0.0125 |
10 |
29 |
a=standard error estimate, b= standard error |